Logo image of EAS2P.AS

EASE2PAY NV (EAS2P.AS) Stock Fundamental Analysis

AMS:EAS2P - NL0000345627 - Common Stock

0.433 EUR
+0 (+0.23%)
Last: 9/10/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EAS2P. EAS2P was compared to 46 industry peers in the Financial Services industry. EAS2P has a great financial health rating, but its profitability evaluates not so good. EAS2P is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EAS2P has reported negative net income.
In the past year EAS2P had a positive cash flow from operations.
EAS2P had negative earnings in each of the past 5 years.
In the past 5 years EAS2P reported 4 times negative operating cash flow.
EAS2P.AS Yearly Net Income VS EBIT VS OCF VS FCFEAS2P.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

EAS2P has a worse Return On Assets (-9.87%) than 84.78% of its industry peers.
EAS2P has a worse Return On Equity (-12.31%) than 80.43% of its industry peers.
Industry RankSector Rank
ROA -9.87%
ROE -12.31%
ROIC N/A
ROA(3y)-89.19%
ROA(5y)-69.44%
ROE(3y)-119.37%
ROE(5y)-121.22%
ROIC(3y)N/A
ROIC(5y)N/A
EAS2P.AS Yearly ROA, ROE, ROICEAS2P.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K 2.5K

1.3 Margins

EAS2P's Gross Margin of 60.88% is in line compared to the rest of the industry. EAS2P outperforms 56.52% of its industry peers.
The Profit Margin and Operating Margin are not available for EAS2P so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EAS2P.AS Yearly Profit, Operating, Gross MarginsEAS2P.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

7

2. Health

2.1 Basic Checks

EAS2P does not have a ROIC to compare to the WACC, probably because it is not profitable.
EAS2P has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for EAS2P has been increased compared to 5 years ago.
There is no outstanding debt for EAS2P. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EAS2P.AS Yearly Shares OutstandingEAS2P.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
EAS2P.AS Yearly Total Debt VS Total AssetsEAS2P.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -1.49, we must say that EAS2P is in the distress zone and has some risk of bankruptcy.
EAS2P has a worse Altman-Z score (-1.49) than 76.09% of its industry peers.
EAS2P has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -1.49
ROIC/WACCN/A
WACC7.4%
EAS2P.AS Yearly LT Debt VS Equity VS FCFEAS2P.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

EAS2P has a Current Ratio of 2.64. This indicates that EAS2P is financially healthy and has no problem in meeting its short term obligations.
EAS2P's Current ratio of 2.64 is amongst the best of the industry. EAS2P outperforms 82.61% of its industry peers.
EAS2P has a Quick Ratio of 2.64. This indicates that EAS2P is financially healthy and has no problem in meeting its short term obligations.
EAS2P's Quick ratio of 2.64 is amongst the best of the industry. EAS2P outperforms 82.61% of its industry peers.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 2.64
EAS2P.AS Yearly Current Assets VS Current LiabilitesEAS2P.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

EAS2P shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.31%, which is quite impressive.
EAS2P shows a small growth in Revenue. In the last year, the Revenue has grown by 7.17%.
The Revenue has been growing by 74.57% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)41.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.71%
Revenue 1Y (TTM)7.17%
Revenue growth 3Y101.26%
Revenue growth 5Y74.57%
Sales Q2Q%23.28%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EAS2P.AS Yearly Revenue VS EstimatesEAS2P.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
EAS2P.AS Yearly EPS VS EstimatesEAS2P.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 0.2 0.4 0.6 0.8 1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

EAS2P reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EAS2P.AS Price Earnings VS Forward Price EarningsEAS2P.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EAS2P indicates a slightly more expensive valuation: EAS2P is more expensive than 69.57% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EAS2P indicates a slightly more expensive valuation: EAS2P is more expensive than 67.39% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 79.01
EV/EBITDA 163.5
EAS2P.AS Per share dataEAS2P.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EAS2P!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EASE2PAY NV

AMS:EAS2P (9/10/2025, 7:00:00 PM)

0.433

+0 (+0.23%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)04-28 2025-04-28
Earnings (Next)09-23 2025-09-23
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.18%
Ins Owner ChangeN/A
Market Cap10.19M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.53
P/FCF 79.01
P/OCF 76.07
P/B 1.56
P/tB 3.68
EV/EBITDA 163.5
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY1.27%
OCF(TTM)0.01
OCFY1.31%
SpS0.12
BVpS0.28
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.87%
ROE -12.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.88%
FCFM 4.47%
ROA(3y)-89.19%
ROA(5y)-69.44%
ROE(3y)-119.37%
ROE(5y)-121.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 0.52%
Cap/Sales 0.17%
Interest Coverage N/A
Cash Conversion 291.3%
Profit Quality N/A
Current Ratio 2.64
Quick Ratio 2.64
Altman-Z -1.49
F-Score7
WACC7.4%
ROIC/WACCN/A
Cap/Depr(3y)0.59%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.25%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.17%
Revenue growth 3Y101.26%
Revenue growth 5Y74.57%
Sales Q2Q%23.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y118.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y119.2%
OCF growth 3YN/A
OCF growth 5YN/A